文献速递牙体牙髓病

氯化十六烷基吡啶/胆固醇甾体脂质体纳米载体的牙本质通透性及内在抗菌活性:体外与体内评价

Evaluation of the transdentinal capability of the intrinsic antibacterial cetylpyridinium chloride/cholesterol sterosomes in vitro and in vivo.
PubMed 文献 · Int Endod J · 2022-11-13

本研究在体外和体内评价了氯化十六烷基吡啶/胆固醇(CPC/Chol)甾体脂质体纳米载体穿透牙本质小管并向牙髓扩散的能力,以及其对四种牙髓感染相关细菌及其生物膜的内在抗菌活性。结果显示该载体可成功穿透牙本质小管扩散至牙髓并被牙髓细胞高效内化,对革兰阳性与阴性牙髓细菌及其生物膜表现出显著内在抗菌活性。作者认为基于甾体脂质体的纳米载体可能成为针对牙髓疾病相关特定通路的潜在治疗策略。

要点

  • CPC/Chol甾体脂质体粒径134 ± 4 nm,多分散指数0.161 ± 0.007,pH 7.4时zeta电位+41 ± 3 mV。
  • 该载体在体外人牙本质块和体内Wistar大鼠磨牙中均可穿透牙本质小管并扩散至牙髓。
  • 该载体可被牙髓细胞高效内化,并对粪肠球菌、变形链球菌、具核梭杆菌和牙龈卟啉单胞菌及其生物膜表现出显著内在抗菌活性。

核心结论

  • 基于甾体脂质体的纳米载体具有高牙本质与牙髓穿透扩散能力、多药递送潜力及独特内在抗菌活性,作者认为其可能成为针对牙髓疾病相关特定通路的潜在治疗策略。

研究设计与样本

  • 本研究为体外与体内实验研究,体外使用人牙本质块评价甾体脂质体的牙本质扩散能力,体内使用Wistar大鼠磨牙进行评价,并进一步检测其对四种牙髓感染相关细菌的内在抗菌活性。

主要发现

  • CPC/Chol甾体脂质体粒径为134 ± 4 nm,多分散指数为0.161 ± 0.007,pH 7.4时zeta电位为+41 ± 3 mV。
  • CPC/Chol甾体脂质体成功穿透牙本质小管并扩散至牙髓,可被牙髓细胞高效内化。
  • CPC/Chol甾体脂质体对粪肠球菌、变形链球菌、具核梭杆菌和牙龈卟啉单胞菌等革兰阳性与革兰阴性牙髓细菌及其生物膜表现出显著的内在抗菌活性。

关键数值与推荐

  • CPC/Chol甾体脂质体粒径134 ± 4 nm,多分散指数0.161 ± 0.007,pH 7.4时zeta电位+41 ± 3 mV。
  • 内在抗菌活性检测对象为粪肠球菌、变形链球菌、具核梭杆菌和牙龈卟啉单胞菌及其生物膜。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Dentinal tubules serve as disease-causing channels for infiltration and penetration of bacteria and their by-products; which are regarded as the major driver of pathogenesis in pulpal inflammation and infection. In this study, we aimed to evaluate the transdentinal potential of nanoscale cetylpyridinium chloride/cholesterol (CPC/Chol) sterosomes, which are a recently developed type of cationic non-phospholipid liposomal nanocarrier; as well as their intrinsic and universal antibacterial activity. METHODOLOGY: Cetylpyridinium chloride/cholesterol sterosomes were formulated, with a hydrodynamic diameter of 134 ± 4 nm, a low polydisperse index of 0.161 ± 0.007, and a positive zeta potential of 41 ± 3 mV at pH 7.4. Transdentinal diffusion ability of sterosomes was evaluated using human dentine blocks in vitro, and Wistar rat molar teeth in vivo. The intrinsic antibacterial activities of CPC/Chol sterosomes against Enterococcus faecalis, Streptococcus mutans, Fusobacterium nucleatum, and Porphyromonas gingivalis were further examined. RESULTS: Cetylpyridinium chloride/cholesterol sterosomes successfully penetrated through the dentinal tubules, and diffused into the pulp, which could be internalized by dental pulp cells with a high efficiency. In addition, they exhibited substantial levels of intrinsic antibacterial activity against these Gram-positive and Gram-negative endodontic bacteria and their biofilms. CONCLUSIONS: Given its high penetration and diffusion ability through the dentine and pulp, great potential for multi-drug delivery, and distinct intrinsic antibacterial activity; sterosome-based nanocarriers might serve as a promising therapeutic strategy aimed at targeting various specific pathways associated with pulpal diseases. This will help determine and characterize the most appropriate prophylactic and therapeutic targets for early intervention in our future dentistry practice.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Yang X, Zhan C, Cheng T, et al. Evaluation of the transdentinal capability of the intrinsic antibacterial cetylpyridinium chloride/cholesterol sterosomes in vitro and in vivo. Int Endod J. 2022. PMID: 36336782. doi:10.1111/iej.13865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。